Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus.

Marcobal A, Liu X, Zhang W, Dimitrov AS, Jia L, Lee PP, Fouts TR, Parks TP, Lagenaur LA.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):964-971. Epub 2016 Apr 13.


A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.

Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B.

Sci Transl Med. 2011 Oct 19;3(105):105ra103. doi: 10.1126/scitranslmed.3002901.


Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1.

Zhang MY, Borges AR, Ptak RG, Wang Y, Dimitrov AS, Alam SM, Wieczorek L, Bouma P, Fouts T, Jiang S, Polonis VR, Haynes BF, Quinnan GV, Montefiori DC, Dimitrov DS.

MAbs. 2010 May-Jun;2(3):266-74. Epub 2010 May 5.


Methods in molecular biology. Therapeutic antibodies. Methods and protocols. Preface.

Dimitrov AS.

Methods Mol Biol. 2009;525:vii-viii, xiii. No abstract available.


Neutralization of HIV by antibodies.

Prado I, Fouts TR, Dimitrov AS.

Methods Mol Biol. 2009;525:517-31, xiv. doi: 10.1007/978-1-59745-554-1_28.


Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS.

Expert Opin Biol Ther. 2009 Mar;9(3):355-68. doi: 10.1517/14712590902763755 . Review. Erratum in: Expert Opin Biol Ther. 2009 Apr;9(4):533.


Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.

Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS.

J Infect Dis. 2008 Mar 15;197(6):846-53. doi: 10.1086/528801.


Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS.

Adv Pharmacol. 2007;55:33-97. Review. No abstract available.


Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.

Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV Jr, Dimitrov DS.

Virology. 2007 Jun 20;363(1):79-90. Epub 2007 Feb 15. Erratum in: Virology. 2007 Nov 25;368(2):431.


Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion.

Dimitrov AS, Jacobs A, Finnegan CM, Stiegler G, Katinger H, Blumenthal R.

Biochemistry. 2007 Feb 6;46(5):1398-401.


Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

Choudhry V, Zhang MY, Harris I, Sidorov IA, Vu B, Dimitrov AS, Fouts T, Dimitrov DS.

Biochem Biophys Res Commun. 2006 Sep 29;348(3):1107-15. Epub 2006 Aug 4.


Antibody-based inhibitors of HIV infection.

Choudhry V, Zhang MY, Dimitrova D, Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS.

Expert Opin Biol Ther. 2006 May;6(5):523-31. Review.


Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.

Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):57-66. Review.


Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, Dimitrov DS.

J Virol. 2006 Jan;80(2):891-9.


Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.

Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA.

J Virol. 2005 Oct;79(19):12231-41.


Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

Dimitrov AS, Louis JM, Bewley CA, Clore GM, Blumenthal R.

Biochemistry. 2005 Sep 20;44(37):12471-9.


Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7. Epub 2005 Jul 5.


Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.

Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC.

J Virol. 2005 Jun;79(11):6690-702.


The SARS-CoV S glycoprotein: expression and functional characterization.

Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS.

Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64.


Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.

Dimitrov AS, Rawat SS, Jiang S, Blumenthal R.

Biochemistry. 2003 Dec 9;42(48):14150-8.


Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.

Dimitrov AS, Xiao X, Dimitrov DS, Blumenthal R.

J Biol Chem. 2001 Aug 10;276(32):30335-41. Epub 2001 Jun 7.


Importance of interfacial water in permeabilization of ceramide bilayers.

Neitchev V, Kostova E, Dimitrov AS.

Histol Histopathol. 1998 Jul;13(3):911-20. doi: 10.14670/HH-13.911. Review.


Supplemental Content

Loading ...
Support Center